vs

Side-by-side financial comparison of Charles River Laboratories (CRL) and TWILIO INC (TWLO). Click either name above to swap in a different company.

TWILIO INC is the larger business by last-quarter revenue ($1.4B vs $995.8M, roughly 1.4× Charles River Laboratories). TWILIO INC runs the higher net margin — 6.4% vs -1.5%, a 7.9% gap on every dollar of revenue. Over the past eight quarters, TWILIO INC's revenue compounded faster (14.0% CAGR vs -1.5%).

Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation (CRO) headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices.

Twilio Inc. is an American cloud communications company based in San Francisco, California, which provides programmable communication tools for making and receiving phone calls, sending and receiving text messages, and performing other communication functions using its web service APIs.

CRL vs TWLO — Head-to-Head

Bigger by revenue
TWLO
TWLO
1.4× larger
TWLO
$1.4B
$995.8M
CRL
Higher net margin
TWLO
TWLO
7.9% more per $
TWLO
6.4%
-1.5%
CRL
Faster 2-yr revenue CAGR
TWLO
TWLO
Annualised
TWLO
14.0%
-1.5%
CRL

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CRL
CRL
TWLO
TWLO
Revenue
$995.8M
$1.4B
Net Profit
$-14.8M
$90.0M
Gross Margin
48.6%
Operating Margin
12.0%
7.7%
Net Margin
-1.5%
6.4%
Revenue YoY
1.2%
Net Profit YoY
-157.2%
EPS (diluted)
$-0.30
$0.57

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CRL
CRL
TWLO
TWLO
Q1 26
$995.8M
$1.4B
Q4 25
$994.2M
$1.4B
Q3 25
$1.0B
$1.3B
Q2 25
$1.0B
$1.2B
Q1 25
$984.2M
$1.2B
Q4 24
$1.0B
$1.2B
Q3 24
$1.0B
$1.1B
Q2 24
$1.0B
$1.1B
Net Profit
CRL
CRL
TWLO
TWLO
Q1 26
$-14.8M
$90.0M
Q4 25
$-276.6M
$-45.9M
Q3 25
$54.4M
$37.2M
Q2 25
$52.3M
$22.4M
Q1 25
$25.5M
$20.0M
Q4 24
$-214.5M
$-12.5M
Q3 24
$69.7M
$-9.7M
Q2 24
$94.1M
$-31.9M
Gross Margin
CRL
CRL
TWLO
TWLO
Q1 26
48.6%
Q4 25
48.5%
Q3 25
48.6%
Q2 25
49.1%
Q1 25
49.6%
Q4 24
50.2%
Q3 24
34.6%
51.0%
Q2 24
34.5%
51.3%
Operating Margin
CRL
CRL
TWLO
TWLO
Q1 26
12.0%
7.7%
Q4 25
-28.5%
4.2%
Q3 25
13.3%
3.1%
Q2 25
9.7%
3.0%
Q1 25
7.6%
2.0%
Q4 24
-16.7%
1.1%
Q3 24
11.6%
-0.4%
Q2 24
14.8%
-1.8%
Net Margin
CRL
CRL
TWLO
TWLO
Q1 26
-1.5%
6.4%
Q4 25
-27.8%
-3.4%
Q3 25
5.4%
2.9%
Q2 25
5.1%
1.8%
Q1 25
2.6%
1.7%
Q4 24
-21.4%
-1.0%
Q3 24
6.9%
-0.9%
Q2 24
9.2%
-2.9%
EPS (diluted)
CRL
CRL
TWLO
TWLO
Q1 26
$-0.30
$0.57
Q4 25
$-5.57
$-0.28
Q3 25
$1.10
$0.23
Q2 25
$1.06
$0.14
Q1 25
$0.50
$0.12
Q4 24
$-4.17
$-0.10
Q3 24
$1.33
$-0.06
Q2 24
$1.74
$-0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CRL
CRL
TWLO
TWLO
Cash + ST InvestmentsLiquidity on hand
$191.8M
$542.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.9B
$7.8B
Total Assets
$7.7B
$9.6B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CRL
CRL
TWLO
TWLO
Q1 26
$191.8M
$542.0M
Q4 25
$213.8M
$682.3M
Q3 25
$207.1M
$734.8M
Q2 25
$182.8M
$969.2M
Q1 25
$229.4M
$467.1M
Q4 24
$194.6M
$421.3M
Q3 24
$210.2M
$584.0M
Q2 24
$179.2M
$755.1M
Total Debt
CRL
CRL
TWLO
TWLO
Q1 26
Q4 25
$2.1B
$992.3M
Q3 25
$2.2B
$991.9M
Q2 25
$2.3B
$991.4M
Q1 25
$2.5B
$991.0M
Q4 24
$2.2B
$990.6M
Q3 24
$2.3B
$990.2M
Q2 24
$2.4B
$989.8M
Stockholders' Equity
CRL
CRL
TWLO
TWLO
Q1 26
$2.9B
$7.8B
Q4 25
$3.2B
$7.8B
Q3 25
$3.4B
$7.9B
Q2 25
$3.4B
$8.0B
Q1 25
$3.2B
$8.0B
Q4 24
$3.5B
$8.0B
Q3 24
$3.8B
$8.2B
Q2 24
$3.7B
$8.7B
Total Assets
CRL
CRL
TWLO
TWLO
Q1 26
$7.7B
$9.6B
Q4 25
$7.1B
$9.8B
Q3 25
$7.5B
$9.7B
Q2 25
$7.6B
$9.8B
Q1 25
$7.6B
$9.8B
Q4 24
$7.5B
$9.9B
Q3 24
$8.0B
$10.0B
Q2 24
$7.9B
$10.5B
Debt / Equity
CRL
CRL
TWLO
TWLO
Q1 26
Q4 25
0.68×
0.13×
Q3 25
0.64×
0.13×
Q2 25
0.70×
0.12×
Q1 25
0.79×
0.12×
Q4 24
0.65×
0.12×
Q3 24
0.62×
0.12×
Q2 24
0.65×
0.11×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CRL
CRL
TWLO
TWLO
Operating Cash FlowLast quarter
$41.1M
$153.0M
Free Cash FlowOCF − Capex
$132.0M
FCF MarginFCF / Revenue
9.4%
Capex IntensityCapex / Revenue
5.6%
Cash ConversionOCF / Net Profit
1.70×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CRL
CRL
TWLO
TWLO
Q1 26
$41.1M
$153.0M
Q4 25
$147.5M
$271.6M
Q3 25
$213.8M
$263.6M
Q2 25
$204.6M
$277.1M
Q1 25
$171.7M
$191.0M
Q4 24
$159.4M
$108.4M
Q3 24
$251.8M
$204.3M
Q2 24
$193.5M
$213.3M
Free Cash Flow
CRL
CRL
TWLO
TWLO
Q1 26
$132.0M
Q4 25
$58.6M
Q3 25
$178.2M
Q2 25
$169.3M
Q1 25
$112.4M
Q4 24
$83.7M
Q3 24
$213.1M
Q2 24
$154.0M
FCF Margin
CRL
CRL
TWLO
TWLO
Q1 26
9.4%
Q4 25
5.9%
Q3 25
17.7%
Q2 25
16.4%
Q1 25
11.4%
Q4 24
8.4%
Q3 24
21.1%
Q2 24
15.0%
Capex Intensity
CRL
CRL
TWLO
TWLO
Q1 26
5.6%
Q4 25
8.9%
Q3 25
3.5%
Q2 25
3.4%
Q1 25
6.0%
Q4 24
7.5%
Q3 24
3.8%
Q2 24
3.8%
Cash Conversion
CRL
CRL
TWLO
TWLO
Q1 26
1.70×
Q4 25
Q3 25
3.93×
7.08×
Q2 25
3.91×
12.36×
Q1 25
6.74×
9.54×
Q4 24
Q3 24
3.61×
Q2 24
2.06×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CRL
CRL

Service revenue$798.2M80%
Product revenue$197.7M20%

TWLO
TWLO

Segment breakdown not available.

Related Comparisons